JP2024539623A5 - - Google Patents
Info
- Publication number
- JP2024539623A5 JP2024539623A5 JP2024522124A JP2024522124A JP2024539623A5 JP 2024539623 A5 JP2024539623 A5 JP 2024539623A5 JP 2024522124 A JP2024522124 A JP 2024522124A JP 2024522124 A JP2024522124 A JP 2024522124A JP 2024539623 A5 JP2024539623 A5 JP 2024539623A5
- Authority
- JP
- Japan
- Prior art keywords
- ketamine
- crystal
- fumarate
- oxalate
- pxrd
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163254878P | 2021-10-12 | 2021-10-12 | |
| US63/254,878 | 2021-10-12 | ||
| PCT/US2022/046412 WO2023064363A1 (en) | 2021-10-12 | 2022-10-12 | R-ketamine salts and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024539623A JP2024539623A (ja) | 2024-10-29 |
| JP2024539623A5 true JP2024539623A5 (cg-RX-API-DMAC10.html) | 2025-10-21 |
Family
ID=84331621
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024522124A Pending JP2024539623A (ja) | 2021-10-12 | 2022-10-12 | R-ケタミン塩及びその使用方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240336556A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4416126A1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2024539623A (cg-RX-API-DMAC10.html) |
| CN (1) | CN118647595A (cg-RX-API-DMAC10.html) |
| CA (1) | CA3234818A1 (cg-RX-API-DMAC10.html) |
| IL (1) | IL312041A (cg-RX-API-DMAC10.html) |
| MX (1) | MX2024004478A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2023064363A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK3043785T3 (da) | 2013-09-13 | 2021-11-15 | Univ Chiba Nat Univ Corp | Anvendelse af r-ketamin og salt deraf som lægemidler |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1444041A2 (en) | 2001-09-21 | 2004-08-11 | Solvias AG | Sealing system with flow channels |
| WO2011115069A1 (ja) * | 2010-03-19 | 2011-09-22 | 第一三共株式会社 | 結晶の網羅的探索 |
| DK3043785T3 (da) | 2013-09-13 | 2021-11-15 | Univ Chiba Nat Univ Corp | Anvendelse af r-ketamin og salt deraf som lægemidler |
| WO2019065900A1 (ja) | 2017-09-27 | 2019-04-04 | 国立大学法人千葉大学 | 神経変性疾患あるいは認知機能障害の予防または治療剤としてのr-ケタミンおよびその誘導体 |
| WO2019160057A1 (ja) | 2018-02-15 | 2019-08-22 | 国立大学法人千葉大学 | 炎症性疾患若しくは骨疾患の予防又は治療剤及び医薬組成物 |
| CN118121577A (zh) | 2018-05-04 | 2024-06-04 | 感知神经科学公司 | 治疗物质滥用的方法 |
| US20220110889A1 (en) | 2018-12-27 | 2022-04-14 | National University Corporation Chiba University | R-ketamine and derivative thereof as prophylactic or therapeutic agent for neurodevelopmental disorder |
| KR20220002905A (ko) * | 2019-03-25 | 2022-01-07 | 더글라스 파머수티클스 리미티드 | 서방형 약학 제제 |
| EP3968979B1 (en) * | 2019-05-15 | 2026-07-01 | Bexson Biomedical, Inc. | KETAMINE FORMULATION FOR SUBCUTANEOUS INJECTION |
| GB201912505D0 (en) * | 2019-08-30 | 2019-10-16 | Klaria Pharma Holding Ab | Pharmaceutical formulation |
-
2022
- 2022-10-12 US US18/700,013 patent/US20240336556A1/en active Pending
- 2022-10-12 JP JP2024522124A patent/JP2024539623A/ja active Pending
- 2022-10-12 MX MX2024004478A patent/MX2024004478A/es unknown
- 2022-10-12 WO PCT/US2022/046412 patent/WO2023064363A1/en not_active Ceased
- 2022-10-12 CA CA3234818A patent/CA3234818A1/en active Pending
- 2022-10-12 EP EP22802347.9A patent/EP4416126A1/en active Pending
- 2022-10-12 CN CN202280081833.8A patent/CN118647595A/zh active Pending
- 2022-10-12 IL IL312041A patent/IL312041A/en unknown